Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 13 projects/programmes
Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients
Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases